Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Amgen Is Up More Than 6% Today


Biopharma stock Amgen (NASDAQ: AMGN) is up 6.4% as of 1:47 p.m. ET Tuesday, according to data from S&P Global Market Intelligence, in response to an upgrade from Morgan Stanley.

It may not be anyone's favorite long-term pick. But given the current market environment, Amgen may be one of an investor's best bets until further notice.

That's the gist of Morgan Stanley's upgrade of Amgen on Tuesday: Analyst Matthew Harrison explained in a note, "We believe Amgen is largely derisked providing defensiveness in this market with upside optionality on growth."

Continue reading


Source Fool.com

Like: 0
Share

Comments